CRIS Current Research Information System

NANNINI, MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.685
AS - Asia 6.417
EU - Europa 5.582
AF - Africa 553
SA - Sud America 384
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.639
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.585
SG - Singapore 2.124
CN - Cina 1.959
IT - Italia 1.335
GB - Regno Unito 1.114
VN - Vietnam 1.018
DE - Germania 666
SE - Svezia 602
HK - Hong Kong 453
IN - India 344
RU - Federazione Russa 314
BR - Brasile 250
IE - Irlanda 240
CH - Svizzera 234
FR - Francia 218
KR - Corea 201
NL - Olanda 179
CI - Costa d'Avorio 173
UA - Ucraina 168
TG - Togo 146
FI - Finlandia 126
ZA - Sudafrica 110
EE - Estonia 95
JP - Giappone 80
AT - Austria 66
CA - Canada 63
AR - Argentina 60
SC - Seychelles 56
ID - Indonesia 52
PL - Polonia 52
JO - Giordania 45
BG - Bulgaria 44
NG - Nigeria 40
BE - Belgio 36
MX - Messico 24
IR - Iran 23
EC - Ecuador 17
ES - Italia 17
GR - Grecia 17
AU - Australia 14
BD - Bangladesh 14
CL - Cile 14
MY - Malesia 14
PK - Pakistan 14
TR - Turchia 14
HR - Croazia 11
IQ - Iraq 11
PE - Perù 11
PY - Paraguay 10
CO - Colombia 9
LT - Lituania 7
CZ - Repubblica Ceca 6
EG - Egitto 6
LB - Libano 6
SK - Slovacchia (Repubblica Slovacca) 6
UY - Uruguay 6
DZ - Algeria 5
IL - Israele 5
MU - Mauritius 5
NI - Nicaragua 5
PT - Portogallo 5
RO - Romania 5
TN - Tunisia 5
UZ - Uzbekistan 5
AO - Angola 4
DK - Danimarca 4
NO - Norvegia 4
PH - Filippine 4
SA - Arabia Saudita 4
TW - Taiwan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
GE - Georgia 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MQ - Martinica 2
NP - Nepal 2
SI - Slovenia 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BO - Bolivia 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
Totale 21.627
Salva come PNG Salva come JPEG
Città #
Singapore 1.412
Ashburn 1.084
Southend 996
Fairfield 903
Chandler 740
Hefei 452
Hong Kong 445
Woodbridge 441
Wilmington 413
Bologna 396
Houston 388
Seattle 370
Santa Clara 355
Cambridge 303
Princeton 287
Ann Arbor 269
Beijing 268
Dublin 240
Bern 219
Ho Chi Minh City 197
Dong Ket 195
Seoul 195
Boardman 178
Abidjan 173
Lomé 146
Redmond 142
Hanoi 141
Dallas 119
New York 118
Nanjing 114
Los Angeles 112
Westminster 111
Berlin 95
Padova 91
Helsinki 82
Jacksonville 82
Milan 80
Redondo Beach 68
Tokyo 66
Turin 65
Jinan 61
Buffalo 59
Rome 57
Munich 53
San Diego 50
Shenyang 49
Amman 45
Vienna 45
Sofia 44
Saint Petersburg 43
Jakarta 41
Bengaluru 39
Frankfurt am Main 39
Abeokuta 38
Nanchang 38
Warsaw 38
Zhengzhou 37
Brussels 36
Falls Church 36
São Paulo 35
Changsha 34
Shanghai 34
Toronto 34
Bremen 32
Hyderabad 32
Jiaxing 31
Guangzhou 30
Hebei 30
Lappeenranta 30
Des Moines 29
Haiphong 28
Florence 27
Tianjin 27
Dearborn 26
Hangzhou 26
London 25
Medford 25
Kuban 24
Phoenix 24
Mülheim 23
Falkenstein 22
Yubileyny 22
Biên Hòa 21
Olalla 21
San Francisco 21
Chicago 20
Nuremberg 20
Amsterdam 18
Fremont 18
Norwalk 18
Redwood City 18
Tongling 18
Bühl 17
Orem 17
Taizhou 17
Cesena 16
Council Bluffs 16
Modena 16
Stockholm 15
Wuhan 15
Totale 14.371
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 402
Comparison of Pathological Scores for Predicting Metastasis in Pheochromocytoma and Paraganglioma: a Single-Center Experience. 309
A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number. 241
Adjuvant chemotherapy for resected colorectal cancer metastases: literature revision and meta-analysis 231
A Single-Centre Experience on the Management of Adenosarcoma: A Successful Report of an Integrated Medical and Surgical Approach 230
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 211
Molecular modelling evaluation of exon 18 His845_Asn848delinsPro pDGFRα mutation in a metastatic GIST patient responding to imatinib 209
Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST. 208
A distinct pediatric-type gastrointestinal stromal tumor in adults: potential role of succinate dehydrogenase subunit A mutations. 206
Chronic therapy in gastrointestinal stromal tumours (GISTs): the big gap between theory and practice 199
Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options 197
Hippo pathway targeting in TP53-mutant Uterine Leiomyosarcoma 194
Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations 192
An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure 190
Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors 189
Genome-wide analysis identifies MEN1 and MAX mutations and a neuroendocrine-like molecular heterogeneity in Quadruple WT GIST 187
Whole Exome Sequencing Uncovers Germline Variants of Cancer-Related Genes in Sporadic Pheochromocytoma 186
Alternative schedules or integration strategies to maximise treatment duration with sunitinib in patients with gastrointestinal stromal tumours. 185
Clinical, radiological and biological features of lung metastases in gastrointestinal stromal tumors (case reports). 182
Whole exome sequencing (WES) on formalin-fixed, paraffin-embedded (FFPE) tumor tissue in gastrointestinal stromal tumors (GIST) 182
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy. 181
Molecular imaging and targeted therapies in oncology: new concepts in treatment response assessment. a collection of cases. 181
Clinical relevance of gene mutations and rearrangements in advanced differentiated thyroid cancer 180
Duration of adjuvant treatment following radical resection of metastases from gastrointestinal stromal tumours. 176
The rs17084733 variant in the KIT 3’ UTR disrupts a miR-221/222 binding site in gastrointestinal stromal tumour: a sponge-like mechanism conferring disease susceptibility 176
Development of a Nephrotic Syndrome in a Patient with Gastrointestinal Stromal Tumor during a Long-Time Treatment with Sunitinib. 175
Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up. 175
Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. 174
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST) 173
Mechanisms of secondary resistance to tyrosine kinase inhibitors in gastrointestinal stromal tumours (Review). 171
An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor 171
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 170
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST 169
Genomic Characterization of Rare Primary Cardiac Sarcoma Entities 168
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 168
Characterization of malignant gastrointestinal stromal tumors-a single center experience. 166
miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs 165
An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild type gastrointestinal stromal tumours - Letter to the editor. 164
Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours. 163
Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre 162
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice 162
Personalization of regorafenib treatment in metastatic gastrointestinal stromal tumours in real-life clinical practice 160
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma 159
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer 159
Insulin-like growth factor 1 receptor expression in wild-type GISTs: a potential novel therapeutic target. 159
Identification of an actionable mutation of kit in a case of extraskeletal myxoid chondrosarcoma 158
Molecular imaging suggests efficacy of bevacizumab beyond the second line in advanced colorectal cancer patients. 156
MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype. 155
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 154
Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors 152
Successful treatment with personalized dosage of imatinib in elderly patients with gastrointestinal stromal tumors 152
Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib 152
An overview on molecular biology of KIT/PDGFRA wild type (WT) gastrointestinal stromal tumours (GIST) 152
Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction. 150
Efficacy of weekly docetaxel in locally advanced cardiac angiosarcoma 148
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 147
Microscopic margins of resection influence primary gastrointestinal stromal tumor survival. 147
SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update 146
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 146
Gene expression profiling in colorectal cancer using microarray technologies: results and perspectives. 145
Successful radiotherapy for local control of progressively increasing metastasis of gastrointestinal stromal tumor. 144
Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas 143
Molecular Imaging of EGFR: It's Time to Go Beyond Receptor Expression 142
Personalized Medicine in Gastrointestinal Stromal Tumor (GIST): Clinical Implications of the Somatic and Germline DNA Analysis 142
Gene Expression Profiling of PDGFRA Mutant GIST Reveals Immune Signatures as a Specific Fingerprint of D842V Exon 18 Mutation 142
Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report 141
Standard versus personalized schedule of regorafenib in metastatic gastrointestinal stromal tumors (GIST): A retrospective, multicenter, real-world study 141
Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense? (Review) 140
Folate-related polymorphisms in gastrointestinal stromal tumours: susceptibility and correlation with tumour characteristics and clinical outcome 140
Surgical second-look in high risk gastrointestinal stromal tumor of small intestine: A case report. 139
Identification of oncogenic events in gastrointestinal stromal tumors (GISTs) by combined gene expression and copy number analysis. 137
SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation 136
Gastrointestinal stromal tumors (GIST): Facing cell death between autophagy and apoptosis 136
Identification of SDHA (subunit A of the succinate dehydrogenase) mutations in KIT/PDGFRA WT gastrointestinal stromal tumors (GISTs). 136
Genomic Database Analysis of Uterine Leiomyosarcoma Mutational Profile 135
KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study 134
SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor 134
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 134
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 133
Integrative analysis of gene expression profiling and high-resolution genomic copy number in gastrointestinal stromal tumor (GIST). 133
The progressive fragmentation of the KIT/PDGFRA wild-type (WT) gastrointestinal stromal tumors (GIST). 133
SDHC methylation in gastrointestinal stromal tumors (GIST): a case report 132
Thoracic myopericytoma in an older adult, rare but possible: A case report 131
Molecular characterization of metastatic exon 11 mutant gastrointestinal stromal tumors (GIST) beyond KIT/PDGFRα genotype evaluated by next generation sequencing (NGS) 131
Microscopic margins of resection in gastrointestinal stromal tumor (GIST): An analysis of 122 patients 131
Management of patients with gastrointestinal stromal tumor in clinical practice in Italy: a critical "event tree model" analysis of decision-making processes and outcomes. 131
Radiotherapy in the management of gist: state of the art and new potential scenarios 129
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report 127
Primary malignant pericardial tumour in Lynch syndrome 127
Molecular Insights in Endometrial Stromal Sarcomas: Exploring New Targets for Novel Therapeutic Approaches 126
Genetic aberrations and molecular biology of cardiac sarcoma 125
Paratesticular Mesenchymal Malignancies: A Single-Center Case Series, Clinical Management, and Review of Literature 124
Quadruplewild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways 123
Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable Gastrointestinal stromal tumours treated with imatinib therapy 123
What is changing in the surgical treatment of gastrointestinal stromal tumors after multidisciplinary approach? A comprehensive literature's review 123
Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case report 123
SDHA and SDHB mutations in KIT/PDGFRA WT gastrointestinal stromal tumors 123
Complete radiological response to first-line regorafenib in a patient with abdominal relapse of BRAF V600E mutated GIST 123
New molecular targets beyond KIT and PDGFRA in gastrointestinal stromal tumors: present and future. Review 122
Totale 16.155
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.202
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.155 0 0 0 0 0 97 25 100 269 107 105 452
2021/20222.670 282 101 110 183 233 119 63 231 125 169 592 462
2022/20233.411 365 495 178 400 190 231 98 203 542 109 267 333
2023/20241.140 124 165 57 131 98 183 63 85 35 61 62 76
2024/20253.805 197 487 338 294 552 171 302 173 77 259 213 742
2025/20264.912 1.114 875 744 714 996 469 0 0 0 0 0 0
Totale 22.137